恒康药房 (871992.oc)

+ 收藏

利润表(恒康药房)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年三季报2023年中报2022年年报2022年三季报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 480,002,118.28344,188,081.90232,548,009.39489,036,407.94330,415,245.62231,399,384.38
 营业收入(元) 480,002,118.28344,188,081.90232,548,009.39489,036,407.94330,415,245.62231,399,384.38
二、营业总成本(元) 446,450,234.32322,199,775.93217,435,909.93458,222,116.61315,516,786.64219,854,152.30
 营业成本(元) 314,609,291.74228,131,333.44155,462,326.29327,670,883.41223,899,234.80158,219,441.74
 研发费用(元) 107,319.9668,081.88-47,245.00--
 营业税金及附加(元) 894,737.03579,551.18361,807.01637,686.22399,401.12254,626.98
 销售费用(元) 113,975,130.9383,205,192.0654,929,233.52115,330,040.5581,254,804.6654,499,410.60
 管理费用(元) 13,040,641.287,460,906.184,943,152.6710,088,270.296,488,731.994,527,842.93
 财务费用(元) 3,823,113.382,754,711.191,739,390.444,447,991.143,474,614.072,352,830.05
  其中:利息费用(元) 3,624,169.162,587,327.061,672,509.814,170,902.653,269,547.75621,287.37
  其中:利息收入(元) 294,428.46167,645.93139,426.81149,717.63116,169.7588,801.28
三、其他经营收益
 加:投资收益(元) ---589,826.95593,551.55593,551.55
 资产处置收益(元) 238,821.21102,471.7818,802.92649,505.0573,558.4844,757.95
 资产减值损失(元) -292,000.76-192,672.55107,529.76-84,472.8923,325.2722,087.33
 信用减值损失(元) -1,161,983.61-701,037.68-220,508.979,296.96272,835.17202,200.24
 其他收益(元) 2,545,247.161,390,613.25974,908.42851,592.29728,609.35717,952.32
四、营业利润(元) 34,881,967.9622,587,680.7715,992,831.5932,830,039.6916,590,338.8013,125,781.47
 加:营业外收入(元) 1,223,330.77201,686.99151,058.5450,475.0456,449.7237,313.68
 减:营业外支出(元) 25,565.7523,920.1025,152.35162,745.32143,608.2525,066.92
五、利润总额(元) 36,079,732.9822,765,447.6616,118,737.7832,717,769.4116,503,180.2713,138,028.23
 减:所得税费用(元) 3,437,356.561,766,639.841,433,346.442,382,044.401,873,651.481,042,169.48
六、净利润(元) 32,642,376.4220,998,807.8214,685,391.3430,335,725.0114,629,528.7912,095,858.75
(一)按经营持续性分类
  持续经营净利润(元) 32,642,376.4220,998,807.8214,685,391.3430,335,725.0114,629,528.7912,095,858.75
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 32,629,513.5120,997,747.2714,683,881.6030,335,725.0114,629,528.7912,095,858.75
  少数股东损益(元) 12,862.911,060.551,509.74---
 扣除非经常性损益后的净利润(元) 30,270,333.8120,371,798.3114,199,709.1330,421,228.17-10,922,477.32
七、每股收益
 一、基本每股收益(元) 0.580.370.260.550.260.22
 二、稀释每股收益(元) 0.580.370.260.550.260.22
九、综合收益总额(元) 32,642,376.4220,998,807.8214,685,391.3430,335,725.0114,629,528.7912,095,858.75
 归属于母公司所有者的综合收益总额(元) 32,629,513.5120,997,747.2714,683,881.6030,335,725.0114,629,528.7912,095,858.75
 归属于少数股东的综合收益总额(元) 12,862.911,060.551,509.74---
公告日期 2024-04-302023-10-312023-08-302023-04-242023-10-312022-08-23
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院